Dr. Nandabalan has over two decades of experience across multiple functions in the pharmaceutical and biotechnology industries, including R&D, operations, business development, M&A and In/Out-licensing. He has garnered a deep understanding of market trends impacting the global healthcare environment, the pharma value chain, the current unmet medical needs, and in applying novel technologies to solve these needs.
Over the course of his career, he has generated significant revenue and shareholder value by completing deals with key industry players such as Pfizer, J&J, AstraZeneca, Pharmacia, BMS, Biogen Idec, Millennium, Merck KGaA, Organon, Sankyo, and Otsuka. He has 12 issued patents and published in leading journals such as Cell and Science. He holds a Ph.D. in Biochemistry and Molecular Biology from the Indian Institute of Science, India and was a Post-Doctoral Fellow at the University of Kentucky and Yale University.